European IP

Thoughts

R 12/21: Petition for review succeeds after EPO Board of Appeal found to violate right to be heard

The petition for review procedure under Article 112a EPC allows parties adversely affected by a decision of the Board of Appeal (BoA) to request a review by the Enlarged Board of Appeal (EBoA). The ba...

CRISPR

The CRISPR therapeutics landscape in 2025

Once confined to science fiction, precise genetic engineering has become a reality and has profoundly impacted modern medicine. CRISPR technology, leveraging guide RNA (gRNA) base pairing to modif...

The Pre-Launch Patent Playbook

The Pre-Launch Patent Playbook: Aligning Patent Risk Assessment with Your Innovation Development Workflows

On 3 June 2025, we held the first webinar in our Pre-Launch Patent Playbook series. Barbara Durling hosted Rike Dekker and Emer Bollinghaus for a discussion on: Aligning Patent Risk Assessment with Yo...

Case law

Dosage regimen patents at the EPO part (II): Recent case law

Dosage regimen patent applications are typically filed a few years after the original application to compounds and their medical uses. Often a clinical trial will already be underway, investigating di...

"A genuine commitment to understanding their clients’ business objectives and consistently providing valuable strategic insights" - Kilburn & Strode retains double gold ranking in IAM Patent 1000

Kilburn & Strode has been awarded gold in both the UK and European Patent Office categories, as well as bronze in The Netherlands, in this year’s IAM Patent 1000.

News

Kilburn & Strode recognised by MIP as tier 1 for Trade Mark prosecution

Kilburn & Strode is proud to have once again been recognised as a tier 1 firm for trade mark prosecution in the 2025 edition of IP Stars, from Managing IP.

Technical Tips

Dosage regimen patents at the EPO part (I): Strategic tips for success

Dosage regimen claims typically refer to compounds for use in treating a condition at a specific frequency of administration, at a specific dose or within a specific dosage range. Sometimes further fe...

Case law

Challenges of extending expired patent rights through trade marks in the medical implant market: Insights from AG Biondi’s Opinion in Case C-17/24

Trade marks can offer very powerful complementary and long-lasting benefits for companies once their patents expire. The term of protection of a patent can give its owner a precious period in which to...

Thoughts

How RNA therapeutics are shaping the future of mental health treatment

This Mental Health Awareness Week, we wanted to highlight how the fast-moving field of RNA therapeutics is being leveraged to treat mental health disorders such as anxiety and depression. We will cove...